Publication: 777

Publication: 777

Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Leuk Lymphoma vol 53 (11) 2143-50

Year:: 2012
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: Received

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 2

Parents:: 508 509
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: CA04457, CA31946, CA32291, CA33601, CA77440, CA77597, CA77651, CA77658

Corr. Author:
Authors:: Lale Kostakoglu Heiko Schöder Jeffrey L Johnson Nathan C Hall Lawrence H Schwartz David J Straus Ann S LaCasce Sin-Ho Jung Nancy L Bartlett George P Canellos Bruce D Cheson

Networks:

Study: CALGB-50203
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Adult, Aged, Disease-Free Survival, Fluorodeoxyglucose F18, Hodgkin Disease, Humans, Middle Aged, Multimodal Imaging, Neoplasm Staging, Positron-Emission Tomography, Prospective Studies, Radiopharmaceuticals, Tomography, X-Ray Computed